Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency
Phase 2/Phase 3
This is a randomised, controlled, open, two-armed, two-period cross-over, multi-centre phase
II/III study to assess the safety, tolerability and pharmacokinetics of once-daily oral
modified-release hydrocortisone in comparison to conventional thrice-daily oral
hydrocortisone tablets in patients with adrenal insufficiency
Single centre, subject and observer blinded, placebo controlled, cross-over study of the
effect of oral ibuprofen and topical hydrocortisone-21-acetate on ultraviolet radiation
(UVR) induced pain and inflammation in healthy volunteers conducted in two segments and
using an intra-individual comparison of application areas.
A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
The purpose of this study is to determine the minimum dose of abiraterone acetate needed to
decrease serum androstenedione to age-appropriate levels in premenopausal women on steroid
replacement for classic 21-hydroxylase deficiency.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.